Curriculum
18 Sections
99 Lessons
6 Weeks
Expand all sections
Collapse all sections
Module 1: Foundations of Obesity as a Chronic Metabolic Disease
6
1.1
Epidemiology and Global Burden of Obesity
1.2
Energy Balance and Regulation of Body Weight
1.3
Neurohormonal Regulation of Appetite and Satiety
1.4
Inflammation, Insulin Resistance, and Adipose Biology
1.5
Metabolic Adaptation and Set-Point Theory
1.6
Obesity Phenotypes and Clinical Staging
Module 2: Clinical Evaluation of the Obesity Patient
5
2.1
Comprehensive Obesity-Focused History
2.2
Anthropometry and Body Composition Assessment
2.3
Laboratory Evaluation and Metabolic Screening
2.4
Identification of Secondary Causes of Obesity
2.5
Cardiometabolic Risk Stratification
Module 3: Clinical Nutrition in Obesity Practice
9
3.1
Macronutrient Science in Obesity
3.2
Protein Requirements and Muscle Preservation
3.3
Carbohydrate Quality, Glycemic Load, and Insulin Response
3.4
Dietary Fat, Fiber, and the Gut Microbiome
3.5
Low-Carbohydrate, Mediterranean, and Balanced Diet Models
3.6
Nutrition Planning During GLP-1 Therapy
3.7
Sarcopenic Obesity and Body Composition–Focused Nutrition
3.8
Micronutrients and Supplementation in Obesity
3.9
Cultural and Vegetarian Diet Adaptations
Module 4: Exercise and Physical Activity Prescription
5
4.1
Exercise Physiology in Obesity
4.2
Resistance Training for Fat Loss and Muscle Preservation
4.3
Aerobic Training and HIIT Protocols
4.4
Exercise Prescription in Special Populations
4.5
Exercise in Insulin Resistance and Metabolic Syndrome
Module 5: Behavioural Medicine and Patient Support
6
5.1
Obesity Stigma and Bias in Healthcare
5.2
Foundations of Motivational Interviewing
5.3
Advanced Behaviour Change Techniques
5.4
Neurobiology of Cravings and Habit Loops
5.5
Emotional Eating and Stress-Related Eating
5.6
Relapse Prevention and Long-Term Adherence
Module 6: GLP-1 Physiology and Mechanisms
4
6.1
Incretin Physiology and the Gut–Brain Axis
6.2
GLP-1 Receptor Signalling Pathways
6.3
Effects on Appetite, Gastric Emptying, and Satiety
6.4
Central Nervous System and Metabolic Effects
Module 7: GLP-1 Receptor Agonists and Dual Agonists – Clinical Overview
6
7.1
Liraglutide in Obesity and Diabetes
7.2
Semaglutide in Weight Management
7.3
Tirzepatide and Dual GIP/GLP-1 Agonism
7.4
Comparative Efficacy and Safety Profiles
7.5
Cardiovascular and Renal Outcome Evidence
7.6
Emerging Incretin-Based Therapies
Module 8: Weight Loss Outcomes and Glycaemic Improvements
6
8.1
Evidence from Major Obesity Clinical Trials
8.2
Body Composition and Visceral Fat Reduction
8.3
HbA1c Reduction and Insulin Resistance Improvement
8.4
Cardiovascular Risk Reduction
8.5
Predictors of Therapeutic Response
8.6
Understanding Weight Loss Plateaus
Module 9: Pharmacotherapy in Obesity
5
9.1
Indications and Guidelines for Anti-Obesity Medications
9.2
Non-GLP-1 Pharmacological Options
9.3
Combination Pharmacotherapy Strategies
9.4
Choosing Therapy Based on Patient Phenotype
9.5
Integration of Pharmacotherapy with Nutrition and Exercise
Module 10: Drug Dosing and Titration in Obesity Pharmacotherapy
6
10.1
Initiation Protocols for GLP-1 Receptor Agonists
10.2
Stepwise Dose Escalation Strategies
10.3
Dosing in Patients with Type 2 Diabetes
10.4
Combination Therapy Titration
10.5
Dose Optimization and Plateau Management
10.6
De-escalation and Transition Planning
Module 11: Safety Monitoring and Adverse Effect Management
5
11.1
Gastrointestinal Adverse Effects and Mitigation
11.2
Pancreatitis and Gallbladder Risk Monitoring
11.3
Thyroid and Endocrine Safety Considerations
11.4
Renal and Hepatic Considerations
11.5
Perioperative and Special Scenario Management
Module 12: Obesity-Linked Metabolic Disorders
6
12.1
Obesity and Type 2 Diabetes (Diabesity Management)
12.2
Insulin De-Intensification Strategies
12.3
Obesity and Polycystic Ovary Syndrome
12.4
Obesity and MASLD (Metabolic Fatty Liver Disease)
12.5
Obesity and Cardiovascular Disease
12.6
Obesity in Chronic Kidney Disease
Module 13: Special Populations in Obesity Medicine
5
13.1
Adolescent Obesity
13.2
Obesity in the Elderly
13.3
Obesity and Pregnancy Planning
13.4
Sarcopenic Obesity
13.5
Resistant and Complex Obesity
Module 14: Bariatric and Metabolic Surgery – Role of the Physician
5
14.1
Indications and Overview of Procedures
14.2
Pre-operative Medical Optimization
14.3
Post-operative Nutritional Monitoring
14.4
Pharmacotherapy After Bariatric Surgery
14.5
Managing Post-Surgical Weight Regain
Module 15: Long-Term Follow-Up and Weight Maintenance
5
15.1
Physiology of Weight Regain
15.2
Maintenance Pharmacotherapy Strategies
15.3
Structured Follow-Up and Monitoring Protocols
15.4
Transitioning Off GLP-1 Therapy
15.5
Sustainable Long-Term Lifestyle Integration
Module 16: Practice Integration for Busy Clinicians
5
16.1
Designing an Obesity-Focused Clinical Workflow
16.2
Structured Consultation Templates
16.3
Team-Based Care Models
16.4
Documentation and Follow-Up Systems
16.5
Digital Monitoring and Remote Care Integration
Module 17: Case Discussions and Logbook
5
17.1
Structured Obesity Consultation Cases
17.2
GLP-1 Titration Case Scenarios
17.3
PCOS, Diabetes, and MASLD Case Management
17.4
Resistant and Complex Obesity Cases
17.5
Logbook Submission and Clinical Audit
Module 18: Final Assessment and Certification
5
18.1
MCQ Examination
18.2
Case-Based OSCE
18.3
Prescription Writing Assessment
18.4
Viva on Pharmacotherapy, Nutrition, and Safety
18.5
Certification Award
Fellowship in Obesity Management
Search
This content is protected, please
login
and enroll in the course to view this content!
WhatsApp us
Home
Courses
Search
Search
Account
Login with your site account
Lost your password?
Remember Me
Modal title
Main Content